Literature DB >> 2671976

Cardiac and extra-cardiac anomalies as indicators for trisomies 13 and 18: a prenatal ultrasound study.

J W Wladimiroff1, P A Stewart, A Reuss, E S Sachs.   

Abstract

The purpose of the present study was to establish sonographic markers for prenatal diagnosis of trisomies 13 and 18. Retrospective analysis of sonographic morphology was therefore carried out in seven fetuses with trisomy 13, and 16 fetuses with trisomy 18. Gestational age ranged between 17 and 39 weeks (median 28 weeks). Polyhydramnios and symmetrical growth retardation were present in 14 of 23 fetuses. A cardiac anomaly was diagnosed in all 23 fetuses, the majority representing a ventricular septal defect (n = 8) or double outlet right ventricle (n = 8). Extra-cardiac anomalies were characterized by a high incidence of limb deformities (polydactyly, clenched hands, club feet; n = 15) and omphalocele (n = 7). We conclude that the combined appearance of cardiac and extra-cardiac anomalies should prompt fetal karyotyping. Cardiac anomalies in combination with fetal limb deformities and omphalocele are suspicious for trisomies 13 and 18.

Entities:  

Mesh:

Year:  1989        PMID: 2671976     DOI: 10.1002/pd.1970090710

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  2 in total

1.  Genome-wide linkage and copy number variation analysis reveals 710 kb duplication on chromosome 1p31.3 responsible for autosomal dominant omphalocele.

Authors:  Uppala Radhakrishna; Swapan K Nath; Ken McElreavey; Uppala Ratnamala; Celi Sun; Amit K Maiti; Maryline Gagnebin; Frédérique Béna; Heather L Newkirk; Andrew J Sharp; David B Everman; Jeffrey C Murray; Charles E Schwartz; Stylianos E Antonarakis; Merlin G Butler
Journal:  J Med Genet       Date:  2012-04       Impact factor: 6.318

2.  Factors influencing the outcome of congenital heart disease detected prenatally.

Authors:  G K Sharland; S M Lockhart; S K Chita; L D Allan
Journal:  Arch Dis Child       Date:  1991-03       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.